Benign Prostatic Hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male; 2. Age: 18~85 years old; 3. IPSS scores >= 8 points.
Exclusion criteria
Exclusion criteria: 1. A previous history of prostate cancer or other pelvic malignant tumors; 2. Non-BPH factors such as neurogenic bladder or urethral stricture that cause lower urinary tract symptoms; 3. Accompanied by severe infectious diseases such as bacteremia and toxemia; 4. Suffering from severe heart, brain, lung, liver, kidney and other diseases and being unable to tolerate surgery; 5. Severe coagulation disorders such as bleeding tendency; 6. Failure to complete follow-up and communication difficulties.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical indicators of disease progression (including changes in IPSS score, changes in maximum urinary flow rate (Qmax), incidence of acute urinary retention (AUR), and rate of surgical intervention);Main baseline patient data (including prostate volume and changes in serum prostate-specific antigen (PSA) levels);Patient clinical outcomes (including watchful waiting, drug therapy, and surgical treatment); | — |
Countries
China
Contacts
The Third Xiangya Hospital of Central South University